RxDoctor Payments Data

Beth Gardner, MD

Gastroenterology · Philadelphia, PANPI 1457334369

Payments from drug & device makers

$121,772in general payments, 2019–2025

Across 1,881 payments — averaging $64.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$53K
  • Aimmune Therapeutics, Inc.$23K
  • Nestle Healthcare Nutrition Inc.$20K
  • Olympus America Inc.$10K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$5K
  • QOL Medical, LLC$2K
  • plus $8K from 27 others

What the payments were for

  • Speaking & faculty fees$87,39472%
  • Travel & lodging$1,3971%
  • Food & beverage$23,23219%
  • Education$210%
  • Other$9,7288%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$121,772 in reported general payments places this provider in the 90th percentile of 935 gastroenterology providers in Pennsylvania.

See all gastroenterology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$189,944
Medicare patients
627
Services billed
1,231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZenpepLipase/Protease/Amylase54$229,529
LinzessLinaclotide192$164,389
Humira(Cf) PenAdalimumab20$133,413
CreonLipase/Protease/Amylase18$108,077
Cimzia (2 Pack)Certolizumab Pegol12$66,132
Alosetron Hcl27$51,654
Mesalamine88$31,360
IbsrelaTenapanor Hcl17$29,080
Dexlansoprazole DrDexlansoprazole40$22,069
Colestipol Hcl276$15,106
Pantoprazole Sodium1,005$14,034
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates199$13,268
TrulancePlecanatide13$12,875
MovantikNaloxegol Oxalate13$11,939
Famotidine832$10,479

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$53,105$272,466210 claims
Aimmune Therapeutics, Inc.Zenpep$23,422$229,52954 claims
UCB, Inc.Cimzia (2 Pack)$207$66,13212 claims
Ardelyx, Inc.Ibsrela$838$29,08017 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$4,812$12,87513 claims
Redhill Biopharma Inc.Movantik$13$11,93913 claims
Phathom Pharmaceuticals, Inc.Voquezna$424$7,58212 claims
Braintree Laboratories, Inc.Sutab$185$3,85924 claims
Ferring Pharmaceuticals Inc.Clenpiq$159$3,23119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 935 gastroenterology providers in Pennsylvania.

Other gastroenterology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →